🇩🇪 Neupogen in Germany

BfArM authorised Neupogen on 15 September 2008

Marketing authorisation

BfArM — authorised 15 September 2008

  • Status: approved

Neupogen in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Neupogen approved in Germany?

Yes. BfArM authorised it on 15 September 2008.

Who is the marketing authorisation holder for Neupogen in Germany?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.